Emulate Events

It’s always an event when we spend time together

:

American College of Toxicology

November 12, 2020 — November 14, 2020
8:00 am — 5:00 pm
Schedule a Call

Synopsis

We are proud exhibitors at the American College of Toxicology’s 41st Annual Meeting. Representatives from our sales team will be available at our virtual booth for the duration event from November 16th-18th, 2020 as well as a poster presentation from Emulate Senior Scientist, Sauveur Jeanty.

The Annual Meeting is an opportunity for scientists, especially from drug development and regulatory sectors, to engage in open exchanges in areas such as the application of toxicology in safety assessment and regulatory settings, as well as the opportunity to interact on a professional basis in a collegial setting. Learn more →

Speaker Spotlight

Sauveur Jeanty

Principal Scientist, Emulate

About Emulate

Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Each of the Emulate proprietary Organ-Chip models—including the liver, intestine, and kidney—contains tiny hollow channels lined with tens of thousands of living human cells and tissues and is approximately the size of an AA battery. An Organ-Chip is a living, microengineered environment that recreates the natural physiology and mechanical forces that cells experience within the human body. Our founding team pioneered the Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Emulate holds the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for the Organs-on-Chips technology and related systems. For more information, please visit emulatebio.com.